Chiral Ligands for Pd-Catalyzed Asymmetric N-Allylations

Chiral Ligands for Pd-Catalyzed Asymmetric N-Allylations

Author: European Journal of Organic Chemistry

The stereo-controlled N-allylation of amino acid derivatives is useful, e.g., for the synthesis of bioactive peptide-related molecules. There is a reliable and general method for such transformations using Pd-based catalysts with chiral C2-symmetric diphosphane ligands, called MediPhos ligands (example pictured above)

Hans-Günther Schmalz and coworkers from the University of Cologne, Germany, have developed an improved synthesis of MediPhos ligands and demonstrated their usefulness in a particularly challenging transformation. The ligands were prepared in high yields via the reaction of a tartaric acid-derived ditosylate with 2-bromo-5-alkyl-phenols, followed by lithiation and phosphanylation (pictured below). The method allows the preparation of MediPhos ligands with bulkier substituents than previous approaches.

 

A 3-pentyl substituted MediPhos ligand enabled the researchers to perform the Pd-catalyzed N-allylation of tert-butyl glycinate using a racemic allyl carbonate with high enantioselectivity. The obtained product was then used to synthesize the bicyclic proline-derived dipeptide mimetic ProM-17 in stereochemically pure form. Readily accessible MediPhos ligands could also have other applications in asymmetric transition-metal catalysis.


 

 

 

 

Leave a Reply

Your email address will not be published.